Cynosure Inc has acquired the assets of Ellman International Inc for approximately $13.2 million in cash. Cynosure has also assumed certain contractual and current liabilities associated with normal working capital as part of the deal.

Ellman’s current annualized revenue run-rate is approximately $25 million. The transaction is expected to be accretive to Cynosure’s earnings per share by the first quarter of 2015.

Ellman develops, manufactures, and markets advanced radiofrequency (RF) technology for precision surgical and aesthetic procedures, and offers a line of aesthetic lasers. Ellman’s product line includes the Pellevé Wrinkle Reduction System, PelleFirm™ RF Body Treatment System, and the Surgitron Surgical RF Systems.

Cynosure’s product portfolio comprises a broad range of energy sources, including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, and Q-switched lasers, and intense pulsed light including Cellulaze, SmartLipo, and Picosure.